{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:38:34Z","timestamp":1784691514110,"version":"3.55.0"},"reference-count":125,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Purpose. Primary fallopian tube carcinoma (PFTC) is a rare tumor that histologically and clinically resembles epithelial ovarian cancer (EOC). The purpose of this study is to review the current available literature data on PFTC.<\/jats:p>\n               <jats:p>Patients and Results. Early clinical manifestation and prompt investigation often lead to diagnosis at an early stage of disease. However, the diagnosis of PFTC is rarely considered preoperatively and is usually first appreciated by the pathologist. Surgical staging\/management and the use of chemotherapy follow the concepts used in epithelial ovarian cancer (EOC). In contrast to EOC is the importance of early lymphatic spread in this disease. The earlier diagnosis of PFTC leads to an apparent better survival compared with EOC. However, as with EOC, stage and residual tumor are the most important prognostic variables.<\/jats:p>\n               <jats:p>Conclusion. Until more extensive clinical research has been performed, ovarian carcinoma management principles should be used in clinical practice.<\/jats:p>","DOI":"10.1634\/theoncologist.11-8-902","type":"journal-article","created":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T23:34:17Z","timestamp":1157153657000},"page":"902-912","source":"Crossref","is-referenced-by-count":124,"title":["Fallopian Tube Carcinoma: A Review"],"prefix":"10.1093","volume":"11","author":[{"given":"Dimitrios","family":"Pectasides","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, Attikon University Hospital, Haidari, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Pectasides","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, Attikon University Hospital, Haidari, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theofanis","family":"Economopoulos","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, Attikon University Hospital, Haidari, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,9,1]]},"reference":[{"key":"2021122208381659800_R1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006254-196104000-00022","article-title":"Primary carcinoma of the fallopian tube","volume":"16","author":"Sedlis","year":"1961","journal-title":"Obstet Gynecol Surv"},{"key":"2021122208381659800_R2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0090-8258(86)90031-4","article-title":"Fallopian tube adenocarcinoma: common extraperitoneal recurrence","volume":"24","author":"Semrad","year":"1986","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0090-8258(82)90067-1","article-title":"Primary adenocarcinoma of the fallopian tube","volume":"13","author":"Roberts","year":"1982","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R4","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1471-0528.1981.tb01766.x","article-title":"Primary carcinoma of the fallopian tube. Report of 22 cases","volume":"88","author":"Raju","year":"1981","journal-title":"Br J Obstet Gynaecol"},{"key":"2021122208381659800_R5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0360-3016(85)90192-0","article-title":"Fallopian tube carcinoma","volume":"11","author":"Brown","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208381659800_R6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0090-8258(84)90178-1","article-title":"Second-look laparotomy in fallopian tube carcinoma","volume":"19","author":"Eddy","year":"1984","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ijc.10970","article-title":"Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953\u201397","volume":"104","author":"Riska","year":"2003","journal-title":"Int J Cancer"},{"key":"2021122208381659800_R8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0090-8258(89)90051-6","article-title":"Incidence of malignant fallopian tube tumors","volume":"35","author":"Rosenblatt","year":"1989","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1525-1438.1997.00455.x","article-title":"Fallopian tube carcinoma: an under-recognized primary neoplasm","volume":"7","author":"Woolas","year":"1997","journal-title":"Int J Gynecol Cancer"},{"key":"2021122208381659800_R10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000010061","article-title":"Management and prognosis of primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma","volume":"47","author":"Rosen","year":"1999","journal-title":"Gynecol Obstet Invest"},{"key":"2021122208381659800_R11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0090-8258(77)90021-X","article-title":"Primary carcinoma of the fallopian tube: difficulties of diagnosis and treatment","volume":"5","author":"Henderson","year":"1977","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0090-8258(88)90022-4","article-title":"Primary adenocarcinoma localized to the fallopian tubes: report on 33 cases","volume":"30","author":"Asmussen","year":"1988","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1525-1438.1994.04060384.x","volume":"4","author":"Woolas","year":"1994","journal-title":"Int J Gynecol Cancer"},{"key":"2021122208381659800_R14","first-page":"571","article-title":"Prognosis of primary fallopian tube adenocarcinoma: report of 25 patients","volume":"19","author":"Wang","year":"1998","journal-title":"Eur J Gynaecol Oncol"},{"key":"2021122208381659800_R15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/ijgc-00009577-200407000-00004","article-title":"Fallopian tube malignancies: experience of Social Security Agency Aegean Maternity Hospital","volume":"14","author":"Inal","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"2021122208381659800_R16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00004347-200104000-00003","article-title":"Clues to the pathogenesis of fallopian tube carcinoma: a morphological and immunohistochemical case control study","volume":"20","author":"Demopoulos","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"2021122208381659800_R17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF00402727","article-title":"Diagnosis of primary adenocarcinoma of the fallopian tube","volume":"110","author":"Meng","year":"1985","journal-title":"J Cancer Res Clin Oncol"},{"key":"2021122208381659800_R18","first-page":"832","article-title":"Primary carcinoma of the fallopian tube","volume":"94","author":"Hanton","year":"1966","journal-title":"Am J Obstet Gynecol"},{"key":"2021122208381659800_R19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF00223867","article-title":"Linkage analysis of 26 Canadian breast and breast-ovarian cancer families","volume":"95","author":"Tonin","year":"1995","journal-title":"Hum Genet"},{"key":"2021122208381659800_R20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/gyno.2000.5740","article-title":"Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report","volume":"77","author":"Rose","year":"2000","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.1999.5623","article-title":"Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations","volume":"76","author":"Zweemer","year":"2000","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/gyno.2000.6095","article-title":"A genetic epidemiological study of carcinoma of the fallopian tube","volume":"80","author":"Aziz","year":"2001","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1067\/mob.2002.119187","article-title":"Fallopian tube cancer in a BRCA1 mutation carrier: rapid development and failure of screening","volume":"186","author":"Hebert-Blouin","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"2021122208381659800_R24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/mp.55.5.305","article-title":"Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer","volume":"55","author":"Jongsma","year":"2002","journal-title":"Mol Pathol"},{"key":"2021122208381659800_R25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00004347-200004000-00007","article-title":"Mucosal epithelial proliferation of the fallopian tube: prevalence, clinical associations, and optimal strategy for histopathologic assessment","volume":"19","author":"Yanai-Inbar","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"2021122208381659800_R26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00000421-198610000-00015","article-title":"Treatment of carcinoma of the fallopian tube using cisplatin, doxorubicin, and cyclophosphamide","volume":"9","author":"Jacobs","year":"1986","journal-title":"Am J Clin Oncol"},{"key":"2021122208381659800_R27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","article-title":"Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis","volume":"80","author":"Paley","year":"2001","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1525-1438.1993.03020065.x","article-title":"Primary adenocarcinoma of the fallopian tube. Review of the literature","volume":"3","author":"Baekelandt","year":"1993","journal-title":"Int J Gynecol Cancer"},{"key":"2021122208381659800_R29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0002-9378(71)90932-X","article-title":"Clinical aspects of primary carcinoma of the Fallopian tube: a clinical study of 14 cases","volume":"111","author":"Boutselis","year":"1971","journal-title":"Am J Obstet Gynecol"},{"key":"2021122208381659800_R30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0039-6109(16)41439-8","article-title":"Carcinoma of the fallopian tube","volume":"58","author":"Sedlis","year":"1978","journal-title":"Surg Clin North Am"},{"key":"2021122208381659800_R31","first-page":"62","article-title":"Tubal adenocarcinoma coexistent with other genital neoplasms","volume":"21","author":"Blaustein","year":"1963","journal-title":"Obstet Gynecol"},{"key":"2021122208381659800_R32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0002-9378(62)90575-6","article-title":"Primary carcinoma of the fallopian tube. A report of 8 cases","volume":"83","author":"Ross","year":"1962","journal-title":"Am J Obstet Gynecol"},{"key":"2021122208381659800_R33","first-page":"935","article-title":"Clinical aspects of fallopian tube carcinoma","volume":"36","author":"Dodson","year":"1970","journal-title":"Obstet Gynecol"},{"key":"2021122208381659800_R34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.ogx.0000158506.23663.79","article-title":"Primary fallopian tube carcinoma","volume":"60","author":"Ajithkumar","year":"2005","journal-title":"Obstet Gynecol Surv"},{"key":"2021122208381659800_R35","first-page":"783","volume-title":"Principles and Practice of Gynecologic Oncology","author":"Markman","year":"1992"},{"key":"2021122208381659800_R36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1525-1438.2001.011001069.x","article-title":"Primary fallopian tube carcinoma: the Queensland experience","volume":"11","author":"Obermair","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"2021122208381659800_R37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1055-3207(18)30276-X","article-title":"Fallopian tube carcinoma","volume":"7","author":"Nikrui","year":"1998","journal-title":"Surg Oncol Clin N Am"},{"key":"2021122208381659800_R38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/gyno.2001.6141","article-title":"Inguinal lymph node metastasis: an unusual presentation of fallopian tube carcinoma","volume":"81","author":"Winter-Roach","year":"2001","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R39","first-page":"278","article-title":"Case report: Bone metastases from fallopian tube carcinoma","volume-title":"Clin Orthop Relat Res","author":"Courville","year":"2005"},{"key":"2021122208381659800_R40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ygyno.2004.06.036","article-title":"Cerebral metastasis from a primary adenocarcinoma of the fallopian tube","volume":"95","author":"Hidaka","year":"2004","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1525-1438.2001.011002169.x","article-title":"Paraneoplastic cerebellar degeneration heralding fallopian tube adenocarcinoma","volume":"11","author":"Levite","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"2021122208381659800_R42","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1471-0528.1976.tb00890.x","article-title":"Carcinoma of the fallopian tube","volume":"83","author":"Chalmers","year":"1976","journal-title":"Br J Obstet Gynaecol"},{"key":"2021122208381659800_R43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/02841868909111173","article-title":"Primary carcinoma of the fallopian tube. A retrospective study of patients reported to the Danish Cancer Registry in a five-year period","volume":"28","author":"Pfeiffer","year":"1989","journal-title":"Acta Oncol"},{"key":"2021122208381659800_R44","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0002-9378(86)90719-2","article-title":"Primary carcinoma of the fallopian tube","volume":"154","author":"Podratz","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"2021122208381659800_R45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1447-0756.1996.tb00966.x","article-title":"Analysis of 23 cases of primary carcinoma of the fallopian tube over 50 years","volume":"22","author":"Huber-Buchholz","year":"1996","journal-title":"J Obstet Gynaecol Res"},{"key":"2021122208381659800_R46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1525-1438.1998.09711.x","article-title":"Survival of patients with primary fallopian tube carcinoma","volume":"8","author":"Vaughan","year":"1998","journal-title":"Int J Gynecol Cancer"},{"key":"2021122208381659800_R47","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1002\/1097-0142(19901215)66:12<2661::AID-CNCR2820661233>3.0.CO;2-T","article-title":"Fallopian tube cancer. The Roswell Park experience","volume":"66","author":"Rose","year":"1990","journal-title":"Cancer"},{"key":"2021122208381659800_R48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/gyno.2001.6134","article-title":"Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study","volume":"81","author":"Gadducci","year":"2001","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R49","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/1097-0142(19861101)58:9<2070::AID-CNCR2820580918>3.0.CO;2-3","article-title":"Carcinoma of the fallopian tube. Management and sites of failure","volume":"58","author":"McMurray","year":"1986","journal-title":"Cancer"},{"key":"2021122208381659800_R50","first-page":"757","article-title":"Prognostic features of carcinoma of the fallopian tube","volume":"71","author":"Peters","year":"1988","journal-title":"Obstet Gynecol"},{"key":"2021122208381659800_R51","first-page":"693","article-title":"Psammoma bodies in cervicovaginal smears","volume":"97","author":"Zreik","year":"2001","journal-title":"Obstet Gynecol"},{"key":"2021122208381659800_R52","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/1097-0142(19900201)65:3<573::AID-CNCR2820650331>3.0.CO;2-4","article-title":"Transvaginal sonography as a screening method for ovarian cancer. A report of the first 1000 cases screened","volume":"65","author":"","year":"1990","journal-title":"Cancer"},{"key":"2021122208381659800_R53","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1471-0528.1990.tb01806.x","article-title":"Novel screening strategies for early ovarian cancer by transabdominal ultrasonography","volume":"97","author":"Campbell","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"2021122208381659800_R54","first-page":"424","article-title":"Transvaginal ultrasonographic study of the fallopian tube","volume":"70","author":"Timor-Tritsch","year":"1987","journal-title":"Obstet Gynecol"},{"key":"2021122208381659800_R55","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/jcu.1870160713","article-title":"Ultrasound appearance of fallopian tube carcinoma","volume":"16","author":"Ajjimakorn","year":"1988","journal-title":"J Clin Ultrasound"},{"key":"2021122208381659800_R56","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7863\/jum.1984.3.9.391","article-title":"Ultrasonic features of fallopian tube carcinoma","volume":"3","author":"Subramanyam","year":"1984","journal-title":"J Ultrasound Med"},{"key":"2021122208381659800_R57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0090-8258(90)90321-B","article-title":"Preoperative diagnosis of fallopian tube carcinoma by transvaginal sonography and CA-125","volume":"37","author":"Kol","year":"1990","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/gyno.1997.4873","article-title":"Preoperative diagnosis of primary fallopian tube carcinoma","volume":"68","author":"Kurjak","year":"1998","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1469-0705.2000.00185.x","article-title":"Three-dimensional ultrasonographic and power Doppler characterization of ovarian lesions","volume":"16","author":"Kurjak","year":"2000","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2021122208381659800_R60","first-page":"63","article-title":"A case of fallopian tube carcinoma: successful preoperative diagnosis with MR imaging","volume":"17","author":"Kurachi","year":"1999","journal-title":"Radiat Med"},{"key":"2021122208381659800_R61","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1148\/radiology.186.2.8380649","article-title":"Primary malignant tumor of the fallopian tube: appearance at CT and MR imaging","volume":"186","author":"Kawakami","year":"1993","journal-title":"Radiology"},{"key":"2021122208381659800_R62","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1006\/gyno.1993.1063","article-title":"Immunohistochemical staining for CA-125 in fallopian tube carcinomas","volume":"48","author":"Puls","year":"1993","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R63","first-page":"703","article-title":"CA125 antigen levels in obstetric and gynecologic patients","volume":"64","author":"Niloff","year":"1984","journal-title":"Obstet Gynecol"},{"key":"2021122208381659800_R64","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0090-8258(90)90137-A","article-title":"Serial measurement of CA 125 in patients with primary carcinoma of the fallopian tube","volume":"36","author":"Tokunaga","year":"1990","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R65","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/1097-0142(20001001)89:7<1555::AID-CNCR20>3.0.CO;2-J","article-title":"The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: a multicenter study","volume":"89","author":"Hefler","year":"2000","journal-title":"Cancer"},{"key":"2021122208381659800_R66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0028-2243(87)90022-0","article-title":"Levels of CA 125 in patients with recurrent carcinoma of the fallopian tube: two case histories","volume":"24","author":"Lootsma-Miklosova","year":"1987","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2021122208381659800_R67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0090-8258(89)90098-X","article-title":"Clinical study of primary carcinoma of the fallopian tube: experience with 15 cases","volume":"34","author":"Hirai","year":"1989","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R68","first-page":"239","article-title":"Primary adenocarcinoma of the fallopian tube","volume":"10","author":"Muntz","year":"1989","journal-title":"Eur J Gynaecol Oncol"},{"key":"2021122208381659800_R69","first-page":"367","article-title":"Cytologic diagnosis of primary tubal cancer","volume":"29","author":"Takashina","year":"1985","journal-title":"Acta Cytol"},{"key":"2021122208381659800_R70","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0090-8258(87)90022-9","article-title":"Primary carcinoma of the fallopian tube: evidence for activity of cisplatin combination therapy","volume":"26","author":"Maxson","year":"1987","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R71","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/gyno.1998.5267","article-title":"Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors","volume":"72","author":"Alvarado-Cabrero","year":"1999","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R72","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0002-9378(50)90341-3","article-title":"Primary carcinoma of the fallopian tube","volume":"59","author":"Hu","year":"1950","journal-title":"Am J Obstet Gynecol"},{"key":"2021122208381659800_R73","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1525-1438.1994.04060395.x","article-title":"Carcinoma of the fallopian tube. A clinical and histopathologic review. The Radiumhemmet series","volume":"4","author":"Hellstrom","year":"1994","journal-title":"Int J Gynecol Cancer"},{"key":"2021122208381659800_R74","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/gyno.1996.0215","article-title":"Fallopian tube cancer: incidence and role of lymphatic spread","volume":"62","author":"di Re","year":"1996","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R75","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/1097-0142(19950615)75:12<2891::AID-CNCR2820751216>3.0.CO;2-B","article-title":"c-erbB-2 and p53 expression in fallopian tube carcinoma","volume":"75","author":"Lacy","year":"1995","journal-title":"Cancer"},{"key":"2021122208381659800_R76","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/gyno.1996.4519","article-title":"Early occurrence and prognostic significance of p53 alteration in primary carcinoma of the fallopian tube","volume":"64","author":"Zheng","year":"1997","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(00)00335-9","article-title":"p53 expression in fallopian tube carcinomas","volume":"156","author":"Rosen","year":"2000","journal-title":"Cancer Lett"},{"key":"2021122208381659800_R78","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00004347-200004000-00008","article-title":"Recurrent fallopian tube carcinoma: TP53 mutation and clinical course","volume":"19","author":"Hellstrom","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"2021122208381659800_R79","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000010212","article-title":"Overexpression of p53 and HER-2\/neu and c-myc in primary fallopian tube carcinoma","volume":"49","author":"Chung","year":"2000","journal-title":"Gynecol Obstet Invest"},{"key":"2021122208381659800_R80","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00006254-197904000-00001","article-title":"Carcinoma of the fallopian tube","volume":"34","author":"Yoonessi","year":"1979","journal-title":"Obstet Gynecol Surv"},{"key":"2021122208381659800_R81","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1097-0142(197108)28:2<389::AID-CNCR2820280219>3.0.CO;2-2","article-title":"Staging and prognosis in primary carcinoma of the fallopian tube","volume":"28","author":"Schiller","year":"1971","journal-title":"Cancer"},{"key":"2021122208381659800_R82","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/0002-9378(76)90855-3","article-title":"Primary carcinoma of the fallopian tube","volume":"125","author":"Kinzel","year":"1976","journal-title":"Am J Obstet Gynecol"},{"key":"2021122208381659800_R83","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0360-3016(97)00586-5","article-title":"Adenocarcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 72 patients","volume":"40","author":"Wolfson","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208381659800_R84","first-page":"223","article-title":"Adenocarcinoma of the fallopian tube","volume":"157","author":"Amendola","year":"1983","journal-title":"Surg Gynecol Obstet"},{"key":"2021122208381659800_R85","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0002-9378(16)32579-0","article-title":"Adenocarcinoma of the uterine tube: potential for lymph node metastases","volume":"141","author":"Tamimi","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"2021122208381659800_R86","first-page":"547","article-title":"Clinical staging of carcinoma of the uterine tube","volume":"30","author":"Erez","year":"1967","journal-title":"Obstet Gynecol"},{"key":"2021122208381659800_R87","first-page":"649","article-title":"Primary adenocarcinoma of the fallopian tube","volume":"32","author":"Momtazee","year":"1968","journal-title":"Obstet Gynecol"},{"key":"2021122208381659800_R88","first-page":"569","article-title":"Total pelvic exenteration for recurrent carcinoma for the uterine tube. Report of a case","volume":"24","author":"Clark","year":"1964","journal-title":"Obstet Gynecol"},{"key":"2021122208381659800_R89","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0304-3835(99)00273-6","article-title":"Lymphadenectomy in primary carcinoma of the fallopian tube","volume":"147","author":"Klein","year":"1999","journal-title":"Cancer Lett"},{"key":"2021122208381659800_R90","first-page":"356","article-title":"Primary cancer of the fallopian tube. Treatment and results of 37 cases","volume":"19","author":"Rauthe","year":"1998","journal-title":"Eur J Gynaecol Oncol"},{"key":"2021122208381659800_R91","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/PL00007475","article-title":"Treatment of fallopian tube cancer. Review of the literature","volume":"264","author":"Takeshima","year":"2000","journal-title":"Arch Gynecol Obstet"},{"key":"2021122208381659800_R92","first-page":"748","article-title":"Second-look laparotomy in carcinoma of the fallopian tube","volume":"82","author":"Barakat","year":"1993","journal-title":"Obstet Gynecol"},{"key":"2021122208381659800_R93","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0090-8258(89)90640-9","article-title":"Carcinoma of the fallopian tube: clinical management","volume":"32","author":"Harrison","year":"1989","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R94","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00000421-199402000-00015","article-title":"Treatment of primary fallopian tube carcinoma with cisplatin-containing chemotherapy","volume":"17","author":"Pectasides","year":"1994","journal-title":"Am J Clin Oncol"},{"key":"2021122208381659800_R95","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/1097-0142(19840101)53:1<166::AID-CNCR2820530129>3.0.CO;2-B","article-title":"The management of primary carcinoma of the fallopian tube. Experience of 40 cases","volume":"53","author":"Denham","year":"1984","journal-title":"Cancer"},{"key":"2021122208381659800_R96","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0090-8258(89)90526-X","article-title":"Fallopian tube carcinoma: a clinicopathological study of 17 cases","volume":"33","author":"King","year":"1989","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R97","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0360-3016(00)01381-X","article-title":"The relevance of adjuvant therapy in primary carcinoma of the fallopian tube, stages I and II: irradiation vs. chemotherapy","volume":"48","author":"Klein","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208381659800_R98","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jnci\/95.2.113","article-title":"International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy in Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma","volume":"95","author":"Trimbos","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"2021122208381659800_R99","first-page":"530","article-title":"Combination chemotherapy for advanced carcinoma of the fallopian tube","volume":"56","author":"Deppe","year":"1980","journal-title":"Obstet Gynecol"},{"key":"2021122208381659800_R100","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0090-8258(90)90290-2","article-title":"Combination chemotherapy in advanced adenocarcinoma of the fallopian tube","volume":"40","author":"Muntz","year":"1991","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R101","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"key":"2021122208381659800_R102","first-page":"108","article-title":"Diagnostic dilemmas and current therapy of fallopian tube cancer","volume":"20","author":"Ben-Hur","year":"1999","journal-title":"Eur J Gynaecol Oncol"},{"key":"2021122208381659800_R103","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1200\/JCO.2000.18.14.2733","article-title":"Docetaxel for patients with paclitaxel-resistant Mullerian carcinoma","volume":"18","author":"Verschraegen","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021122208381659800_R104","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/gyno.2000.6012","article-title":"Paclitaxel-based chemotherapy in carcinoma of the fallopian tube","volume":"80","author":"Gemignani","year":"2001","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R105","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/1097-0142(20001115)89:10<2076::AID-CNCR7>3.0.CO;2-V","article-title":"Carcinoma of the fallopian tube","volume":"89","author":"Baekelandt","year":"2000","journal-title":"Cancer"},{"key":"2021122208381659800_R106","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/gyno.1995.1222","article-title":"Primary fallopian tube adenocarcinoma: clinical complete response after salvage treatment with high-dose paclitaxel","volume":"58","author":"Tresukosol","year":"1995","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R107","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/gyno.2000.5726","article-title":"Metachronous carcinoma of the vulva and fallopian tube","volume":"77","author":"Ichikawa","year":"2000","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R108","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1200\/JCO.2001.19.7.1901","article-title":"Combination chemotherapy with carboplatin and docetaxel in the treatment of cancers of the ovary and fallopian tube and primary carcinoma of the peritoneum","volume":"19","author":"Markman","year":"2001","journal-title":"J Clin Oncol"},{"key":"2021122208381659800_R109","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1200\/JCO.1998.16.10.3345","article-title":"Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel","volume":"16","author":"Bookman","year":"1998","journal-title":"J Clin Oncol"},{"key":"2021122208381659800_R110","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1200\/JCO.1998.16.6.2233","article-title":"Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group study","volume":"16","author":"Hoskins","year":"1998","journal-title":"J Clin Oncol"},{"key":"2021122208381659800_R111","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/gyno.1999.5630","article-title":"Complete response to topotecan of recurrent fallopian tube carcinoma","volume":"76","author":"Dunton","year":"2000","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R112","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/gyno.2000.6006","article-title":"A phase I trial of a 3-day topotecan Q 21 days for recurrent epithelial cancers of the ovary, fallopian tube, and peritoneum","volume":"79","author":"Brown","year":"2000","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R113","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/gyno.2000.5902","article-title":"Phase 2 evaluation of topotecan administered on a 3-day schedule in the treatment of platinum- and paclitaxel-refractory ovarian cancer","volume":"79","author":"Markman","year":"2000","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R114","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1200\/JCO.1997.15.3.987","article-title":"Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation","volume":"15","author":"Muggia","year":"1997","journal-title":"J Clin Oncol"},{"key":"2021122208381659800_R115","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2000.18.17.3093","article-title":"Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer","volume":"18","author":"Gordon","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021122208381659800_R116","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/gyno.2000.5921","article-title":"Phase 2 trial of liposomal doxorubicin (40 mg\/m(2)) in platinum\/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum","volume":"78","author":"Markman","year":"2000","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R117","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0301-2115(99)00264-X","article-title":"Primary carcinoma of the fallopian tube: study of 11 cases","volume":"91","author":"Piura","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2021122208381659800_R118","first-page":"853","volume-title":"Gynecologic Oncology: Fundamental Principles and Clinical Practice","author":"Benedet","year":"1992"},{"key":"2021122208381659800_R119","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/bjc.1993.394","article-title":"Primary carcinoma of the fallopian tube--a retrospective analysis of 115 patients. Austrian Cooperative Study Group for Fallopian Tube Carcinoma","volume":"68","author":"Rosen","year":"1993","journal-title":"Br J Cancer"},{"key":"2021122208381659800_R120","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/gyno.2002.6743","article-title":"Treatment and survival for women with Fallopian tube carcinoma: a population-based study","volume":"86","author":"Kosary","year":"2002","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R121","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00004347-199707000-00001","article-title":"Tumors of the fimbriated end of the fallopian tube: a clinicopathologic analysis of 20 cases, including nine carcinomas","volume":"16","author":"Alvarado-Cabrero","year":"1997","journal-title":"Int J Gynecol Pathol"},{"key":"2021122208381659800_R122","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1006\/gyno.1994.1302","article-title":"Lymphogenous metastasis in the primary carcinoma of the fallopian tube","volume":"55","author":"Klein","year":"1994","journal-title":"Gynecol Oncol"},{"key":"2021122208381659800_R123","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/00003081-196209000-00022","article-title":"Tumors of the fallopian tube","volume":"5","author":"Green","year":"1962","journal-title":"Clin Obstet Gynecol"},{"key":"2021122208381659800_R124","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3835(01)00801-1","article-title":"Tumor progression, histologic grading and DNA-ploidy as predictive factors of lymphogenous metastasis in primary carcinoma of the fallopian tube","volume":"177","author":"Klein","year":"2002","journal-title":"Cancer Lett"},{"key":"2021122208381659800_R125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00001703-200202000-00005","article-title":"Current management of fallopian tube carcinoma","volume":"14","author":"Gadducci","year":"2002","journal-title":"Curr Opin Obstet Gynecol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.11-8-902","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.11-8-902","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/11\/8\/902\/41851256\/oncolo_11_8_902.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/11\/8\/902\/41851256\/oncolo_11_8_902.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T14:41:24Z","timestamp":1640184084000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/11\/8\/902\/6397105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,1]]},"references-count":125,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2006,9,1]]},"published-print":{"date-parts":[[2006,9,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.11-8-902","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,9,1]]},"published":{"date-parts":[[2006,9,1]]}}}